First, we retrieved the names of FDA-approved, currently used (i.e., not discontinued) drugs for DM2 from DrugBank 36 and the KEGG 30 databases, specifically from the Type II diabetes mellitus pathway entry (hsa04930) and disease entry H00409
Although clinical trials have demonstrated the safety and tolerability of GLP-1RAs, side effects, especially gastrointestinal-related, are known to affect up to 1040% of users [13, 15]
Participants in Phase 2 trials reported the injection process to be generally well tolerated
This is more informative than claiming high-quality ingredients with no further explanation
You cant be taking other GLP-1 drugs like Ozempic or Saxenda at the same time
Diabetes Metab Res Rev (2010) 26(4):28796